Abstract
Brachytherapy is a valuable treatment modality that offers clinical and logistical advantages when compared to the conventional Neo‐EBRT in soft tissue sarcomas. Brachytherapy offers a lower risk of wound complications and a comparable local control. This manuscript presents decision‐making strategies for determining the appropriate radiation modality for specific circumstances.